The BIOGRAM (Difco Laboratories, Detroit, Mich.) 
The disk agar diffusion test is a highly standardized and acceptable qualitative test used for the determination of in vitro susceptibility of most clinical isolates (5, 12) . It offers clinical microbiology laboratories the advantage of selecting their own batteries of routine antimicrobial agents for testing, with highly accurate and reproducible results (8, 11) . In a recent survey (6) , most Thornsberry and McDougal (14) , were tested by both systems. The antimicrobial agents tested in each commercial system are listed in Tables 1 to 4 . Common bacterial suspensions prepared in Trypticase soy broth (BBL) for disk testing also served as inocula in the Sceptor system (diluted 1:100 in 10 ml of Sceptor broth). In the UniScept system, inoculum was prepared in 0.85% NaCl and diluted to give a final concentration of approximately 105 CFU/ml. Quality control. Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, Staphylococcus aureus ATCC 29213, Staphylococcus aureus ATCC 25923, and two known methicillin-resistant (heteroresistant) Staphylococcus aureus strains (College of American Pathologists 1984 Survey no. B12 and patient clinical isolate) were used to control the performance of each test system (3) . Quality control strains were tested at least weekly in accordance with the National Committee for Clinical Laboratory Standards.
Analysis of data. The comparative results were expressed as ratios of the BIOGRAM MIC divided by the commercial microdilution MIC; this ratio is similar to that used by D'Amato et al. (1) . Results were considered in agreement (±1 log2 dilution) when the calculated BIOGRAM MIC and microdilution MIC ratios ranged from 0.5 to 2.0.
RESULTS
The MIC agreement, as determined by calculating the ratio between the MICs determined with BIOGRAM and Sceptor systems, is shown in Tables 1 and 2 . Overall agreement between the BIOGRAM and Sceptor MICs for staphylococci was 93.6% (Table 1) . For cefamandole and gentamicin (less than 90% agreement), the trend was toward higher MICs with the BIOGRAM system. All 48 strains of methicillin-resistant S. aureus were detected with the BIOGRAM system, whereas the Sceptor system failed to detect two methicillin-resistant and one oxacillin-resistant S. aureus strains. For methicillin the trend was toward lower MIC ratios with the Sceptor system, with 9.4% having a ratio of less than 0.5. The results of this evaluation indicate that the MIC determinations with the BIOGRAM system correlated very well with those with the Sceptor system. Significantly lower agreement, however, was noted between the MICs determined with the BIOGRAM and UniScept systems. Although UniScept has generally been found to be a reliable and accurate method (4), it is our experience that it is more inoculum dependent than other commercial MIC systems (unpublished data). Variations in inoculum density have been demonstrated with the use of disposable inoculators (2) . Complete agreement between the BIOGRAM and commercial systems was lower than the reference MIC method evaluated previously (1). These differences are presumably due to the resistant organisms that were selected for use in this study and the test methodologies that were compared.
Oxacillin-resistant staphylococci were detected more frequently by the BIOGRAM system than by the commercial broth dilution systems, despite the addition of 2% NaCI to the panels. Discrepant MIC results for P-lactam antimicrobial agents between the dilution and BIOGRAM methods may be explained by staphylococcal P-lactamase production. P-Lactamase-positive strains have been shown to have smaller zones than P-lactamase-negative strains at the same MIC (9) . The difficulty in detecting methicillin-resistant strains of S. aureus appears to be due to the fact that methicillin is more resistant to the action of ,B-lactamase than is oxacillin (10) . The disk agar diffusion method (12) incorporated in the BIOGRAM system is more reliable for the detection of methicillin-resistant (heteroresistant) staphylococci. Erythromycin discrepancies between the MIC ratios determined with the BIOGRAM and UniScept systems cannot be explained because they were not observed with either the Sceptor or reference methods.
The BIOGRAM system offers several advantages to clinical laboratories that currently perform disk agar diffusion testing. It is designed to automate and further standardize this established procedure. In addition to reporting MICs, inhibitory quotients, and drug cost factors, the BIOGRAM data management center is equipped to perform epidemiological analysis and to plot antimicrobial agent distributions by zone diameter or MIC. The BIOGRAM system eliminates the need for laboratories to maintain additional quantitative MIC panels and quality control testing. Also, it does not restrict the selection and timely reporting of antimicrobial agents tested both qualitatively and quantitatively. We conclude that the BIOGRAM system is an acceptable alternative method to the commercial broth microdilution MIC systems tested and that disk agar diffusion is preferred for the detection of methicillin-resistant staphylococci.
